Skip to main content
. 2020 Jan 21;2020:1042329. doi: 10.1155/2020/1042329

Table 2.

Patients and lesion characteristics of the included studies.

Study Group Target vessel, % RVD, mm MLD, mm DS%, % LVEF, % UA, % SA/SI, % ISR Mehran classification, %
LAD LCX RCA VB I II III-IV
DARE, 2018 [5] DCB 41.0% 0.0% 37.0% 0.7% 2.56 ± 0.43 0.77 ± 0.33 69.7 ± 11.8 NR 44% NR 51% 32% 17%
EES 39.0% 0.7% 35.0% 1.4% 2.59 ± 0.54 0.79 ± 0.35 69.3 ± 12.5 NR 42% NR 53% 34% 13%
RESTORE, 2018 [4] DCB 55.8% 15.1% 27.9% 1.2% 2.85 ± 0.50 0.63 ± 0.40 77 ± 17 59.4% ± 8.4% 45.30% 41.80% 67.20% 14.90% 17.90%
EES 60.5% 12.8% 24.4% 0.0% 3.06 ± 0.45 0.63 ± 0.42 79 ± 13 59.9% ± 7.8% 38.40% 45.40% 66.20% 19.10% 14.70%
RIBS IV, 2015 [9, 12] DCB 37.0% 22.0% 39.0% 2.0% 2.64 ± 0.60 1.02 ± 0.40 61 ± 14 58% ± 13% 40% 60% 63% 34% 3%
EES 39.0% 23.0% 34.0% 3.0% 2.64 ± 0.60 0.93 ± 0.40 65 ± 13 59% ±1 2% 45% 56% 64% 28% 8%
RIBS V, 2014 [11, 14] DCB 50.0% 18.0% 28.0% 4.0% 2.58 ± 0.50 0.79 ± 0.40 69 ± 17 58% ± 12% 52% 48% 40% 47% 13%
EES 46.0% 22.0% 29.0% 3.0% 2.55 ± 0.50 0.75 ± 0.40 72 ± 15 59% ± 11% 51% 49% 36% 45% 19%
SEDUCE, 2014 [10] DCB 24.0% 20.0% 52.0% 4.0% 3.00 ± 0.48 0.98 ± 0.60 67.7 ± 18.4 NR 20% 76% 32% 52% 16%
EES 44.0% 28.0% 24.0% 0.0% 2.85 ± 0.44 0.57 ± 0.37 79.4 ± 13.5 NR 20% 76% 36% 40% 24%
TIS, 2016 [6, 12] DCB 47.3% NR 29.7% 1.4% 2.64 ± 0.47 0.92 ± 0.45 71.8 ± 13.9 49.7% ± 12.0% NR 64.70% 40.54% 45.95% 13.52%
EES 54.1% NR 29.7% 2.7% 2.66 ± 0.45 0.79 ± 0.48 78.0 ± 13.4 49.6% ± 11.4% NR 63.20% 28.38% 47.30% 24.32%

Data are shown as percentage or mean ± standard deviation. DCB, drug-coated balloons; EES, everolimus-eluting stents; LAD, anterior descending branch; LCX, left circumflex artery; RCA, right coronary artery; VB, vein bypass; RVD, reference vessel diameter; MLD, minimum lumen diameter; DS, diameter stenosis; LVEF, left ventricular ejection fraction; UA, unstable angina; SA/SI, stable angina/silent ischemia; ISR, in-stent stenosis; NR, not reported.